Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by ReShape Lifesciences Inc.
ReShape Reports Second Quarter 2021 Financial Results and Provides Business Update
August 16, 2021
From
ReShape Lifesciences Inc.
Via
AccessWire
Tickers
RSLS
ReShape Lifesciences Reports Preliminary Unaudited Second Quarter 2021 Financial Results and Provides Business Update
August 05, 2021
From
ReShape Lifesciences Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Tickers
RSLS
ReShape Lifesciences(TM) CEO Bart Bandy Featured on the Big Biz Show
August 03, 2021
From
ReShape Lifesciences Inc.
Via
AccessWire
Tickers
RSLS
ReShape Lifesciences to Report Second Quarter 2021 Financial and Operational Results on Thursday, August 5, 2021
July 29, 2021
From
ReShape Lifesciences Inc.
Via
AccessWire
Tickers
RSLS
ReShape Lifesciences(TM) Launches Online Consumer Marketplace Offering Products Supporting Four Key Dimensions of Wellness: Nutrition, Exercise, Sleep and Stress
July 13, 2021
From
ReShape Lifesciences Inc.
Via
AccessWire
Tickers
RSLS
ReShape Lifesciences Moves Lap-Band Manufacturing to United States
July 07, 2021
From
ReShape Lifesciences Inc.
Via
AccessWire
Tickers
RSLS
ReShape Lifesciences Sees Lap-Band Growth as COVID-19 Pandemic Heightens Obesity Crisis
July 01, 2021
From
ReShape Lifesciences Inc.
Via
AccessWire
Exposures
COVID-19
Tickers
RSLS
ReShape Lifesciences Completes $46 Million Capital Raise With Key Institutional Shareholders
June 30, 2021
From
ReShape Lifesciences Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Tickers
RSLS
ReShape Lifesciences Enters into Warrant Exercise Transaction for $46.2 Million in Gross Proceeds
June 29, 2021
From
ReShape Lifesciences Inc.
Via
AccessWire
Tickers
RSLS
ReShape Lifesciences Closes First Day of Trading on the NASDAQ Capital Market
June 17, 2021
From
ReShape Lifesciences Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Tickers
RSLS
ReShape Lifesciences Completes Merger with Obalon Therapeutics
June 16, 2021
From
ReShape Lifesciences Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Product Safety
Regulatory
Tickers
RSLS
ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Announce Anticipated Closing of Merger
June 15, 2021
From
ReShape Lifesciences Inc.
Via
AccessWire
Tickers
RSLS
ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Update on Status of Pending Merger
June 08, 2021
From
ReShape Lifesciences Inc.
Via
AccessWire
Tickers
RSLS
Reminder: Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences
May 24, 2021
From
ReShape Lifesciences Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Tickers
RSLS
Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences
May 21, 2021
From
ReShape Lifesciences Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Tickers
RSLS
Obalon Therapeutics Stockholders Special Meeting Adjourned to May 25, 2021
May 18, 2021
From
ReShape Lifesciences Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Tickers
RSLS
ReShape Lifesciences Announces First Quarter 2021 Financial and Operational Results
May 17, 2021
From
ReShape Lifesciences Inc.
Via
AccessWire
Topics
Fraud
Intellectual Property
Exposures
COVID-19
Intellectual Property
Legal
Tickers
RSLS
Obalon Therapeutics, Inc. Urges Stockholders to IMMEDIATELY Vote FOR All Proposals Related to the Merger with ReShape Lifesciences Inc
May 12, 2021
From
ReShape Lifesciences Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.